|Other Names||Bombesin receptor-activated protein C6orf89, Amfion, C6orf89, BRAP|
|Target/Specificity||The synthetic peptide sequence used to generate the antibody AP13887c was selected from the Center region of C6orf89. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||Exhibits histone deacetylase (HDAC) enhancer properties (PubMed:23460338). May play a role in cell cycle progression and wound repair of bronchial epithelial cells (PubMed:21857995).|
|Cellular Location||Isoform 1: Golgi apparatus membrane; Single-pass type II membrane protein. Midbody Isoform 3: Cytoplasm. Nucleus, nucleolus Note=Retained in nucleolar organiser regions (NORs) in mitotic cells (PubMed:23460338).|
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Zhang, J.K., et al. World J. Gastroenterol. 13(10):1602-1607(2007)Mungall, A.J., et al. Nature 425(6960):805-811(2003)Clark, H.F., et al. Genome Res. 13(10):2265-2270(2003)
If you have any additional inquiries please email technical services at firstname.lastname@example.org.